Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 2/20 | 0.53 |
| ▸ | CTSL | P07711 | 1/20 | 0.53 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | CTSC | P53634 | 2/20 | 0.51 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.50 |
| ▸ | CHRNG | P07510 | 2/20 | 0.50 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.50 |
| ▸ | CHRND | Q07001 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.49 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.49 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.49 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26605054 | 1.00 | CTSS (0.53) | CTSSCTSLCTSBCTSCCHRNA1 | |
| SCHEMBL18515809 | 0.93 | OPRD1 (0.51) | CTSSCTSLCTSBCHRNA1CHRNG | |
| SCHEMBL30051602 | 0.90 | CTSS (0.54) | CTSSCTSLCTSBCTSCCHRNA1 | |
| SCHEMBL7587101 | 0.90 | CTSS (0.54) | CTSSCTSLCTSBCTSCCHRNA1 | |
| SCHEMBL1848846 | 0.90 | CTSS (0.54) | CTSSCTSLCTSBCTSCCHRNA1 | |
| SCHEMBL5177691 | 0.88 | CHRND (0.53) | CHRNA1CHRNGCHRNB1CHRNDCHRNB2 | |
| SCHEMBL23937555 | 0.88 | CTSS (0.55) | CTSSCTSLCTSBCTSCCHRNA1 | |
| SCHEMBL29789610 | 0.88 | CTSL (0.52) | CTSSCTSLCTSBCTSCCHRNA1 | |
| SCHEMBL29789562 | 0.88 | OPRD1 (0.53) | CTSSCTSLCTSBCTSCCHRNA1 | |
| SCHEMBL20880553 | 0.87 | CHRNB2 (0.49) | CTSSCTSLCTSBCTSCCHRNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257111-A1 | Supramolecular Complex of a Biomolecule | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| EP-4511382-A1 | SUPRAMOLECULAR COMPLEX OF A BIOMOLECULE | Cambridge Enterprise Limited (GB) | 2025-02-26 | — | — | EP | disclosed |
| CN-119233979-A | Supramolecular complexes of biomolecules | 剑桥实业有限公司 | 2024-12-31 | — | — | CN | disclosed |
| WO-2023203201-A1 | SUPRAMOLECULAR COMPLEX OF A BIOMOLECULE | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2023-10-26 | — | — | WO | disclosed |
| US-20070037249-A1 | Molecules that block viral infectivity and methods of use thereof | GOOBAR-LARSSON LAURA | 2007-02-15 | — | — | US | disclosed |
| US-7012129-B2 | Antiviral composition comprising glycine amide | TRIPEP AB (SE) | 2006-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257111-A1 | Supramolecular Complex of a Biomolecule | CCR8, IGFBP1, IGFBP2 | CTSS 1454/4885CTSL 462/4885CTSB 1290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.